BRSP Stock Analysis: Brightspire Capital | NYSE
REIT - Mortgage | NYSE, USA | Market Cap: 431m USD | 12M Return: -29.5% | US10949T1097 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 6.81M
EPS Trend: -96.9%
Qual. Beats: -3
Rev. Trend: -87.5%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 8.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
BrightSpire Capital, Inc. (NYSE: BRSP) is a commercial real estate (CRE) credit real estate investment trust (REIT) that originates, acquires, finances, and manages a diversified portfolio of CRE debt investments, including senior mortgage loans, mezzanine loans, preferred equity investments, net leased real estate, and CRE debt securities. The company operates through three segments: Senior and Mezzanine Loans and Preferred Equity; Net Leased and Other Real Estate; and Corporate and Other, with operations spanning the United States and Norway.
As a REIT, BrightSpire benefits from a pass-through tax structure, avoiding federal corporate income tax provided it distributes at least 90% of its taxable income to shareholders. CRE credit REITs like BrightSpire typically generate income from interest payments and lease revenue rather than direct property appreciation, distinguishing them from equity REITs that own and operate properties. The company was incorporated in 2017, is headquartered in New York, and was previously known as Colony Credit Real Estate, Inc. before rebranding in June 2021.
- Net interest margin compresses amid Fed rate cuts
- Office sector distress pressures CRE loan portfolio valuations
- REIT distribution requirements limit retained capital flexibility
| Net Income: 19.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.58 > 1.0 |
| NWC/Revenue: 58.36% < 20% (prev 726.0%; Δ -667.6% < -1%) |
| CFO/TA 0.02 > 3% & CFO 72.2m > Net Income 19.1m |
| Net Debt (2.64b) to EBITDA (159.1m): 16.57 < 3 |
| Current Ratio: 4.71 > 1.5 & < 3 |
| Outstanding Shares: last quarter (122.9m) vs 12m ago -5.35% < -2% |
| Gross Margin: 49.25% > 18% (prev 50.66%; Δ -1.41% > 0.5%) |
| Asset Turnover: 9.65% > 50% (prev 9.89%; Δ -0.24% > 0%) |
| Interest Coverage Ratio: 0.93 > 6 (EBIT TTM 130.2m / Interest Expense TTM 139.4m) |
| A: 0.05 (Total Current Assets 249.1m - Total Current Liabilities 52.9m) / Total Assets 3.67b |
| B: -0.53 (Retained Earnings -1.96b / Total Assets 3.67b) |
| C: 0.04 (EBIT TTM 130.2m / Avg Total Assets 3.49b) |
| D: 0.32 (Book Value of Equity 883.1m / Total Liabilities 2.80b) |
| Altman-Z'' = -0.81 = CCC |
| DSRI: 0.10 (Receivables 39.5m/2.29b, Revenue 336.2m/326.8m) |
| GMI: 1.03 (GM 50.66% / 49.25%) |
| AQI: 3.52 (AQ_t 0.82 / AQ_t-1 0.23) |
| SGI: 1.03 (Revenue 336.2m / 326.8m) |
| TATA: -0.01 (NI 19.1m - CFO 72.2m) / TA 3.67b) |
| Beneish M = -2.23 (Cap -4..+1) = BBB |
As of November 10, 2026, the stock is trading at USD 3.37 with a total of 1,249,763 shares traded. Over the past week, the price has changed by -5.60%, over one month by -11.55%, over three months by -28.38% and over the past year by -29.51%.
Current recommended Stop Loss: 3.10 (which is 8% or 1.7 ATR below the current price).
Brightspire Capital has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy BRSP.
- StrongBuy: 4
- Buy: 2
- Hold: 0
- Sell: 2
- StrongSell: 0
| Analysts Target Price | 5.8 | 70.6% |
P/E Trailing = 26.6154
P/E Forward = 6.215
P/S = 1.2831
P/B = 0.4913
Revenue TTM = 336.2m USD
EBIT TTM = 130.2m USD
EBITDA TTM = 159.1m USD
Long Term Debt = 2.63b USD (from longTermDebt, last quarter)
Short Term Debt = 52.9m USD (from shortTermDebt, last quarter)
Debt = 2.70b USD (corrected: LT Debt 2.63b + ST Debt 52.9m) + Leases 12.1m
Net Debt = 2.64b USD (calculated: Debt 2.70b - CCE 63.6m)
Enterprise Value = 3.07b USD (431.4m + Debt 2.70b - CCE 63.6m)
Interest Coverage Ratio = 0.93 (Ebit TTM 130.2m / Interest Expense TTM 139.4m)
EV/FCF = 43.63x (Enterprise Value 3.07b / FCF TTM 70.3m)
FCF Yield = 2.29% (FCF TTM 70.3m / Enterprise Value 3.07b)
FCF Margin = 20.91% (FCF TTM 70.3m / Revenue TTM 336.2m)
Net Margin = 5.68% (Net Income TTM 19.1m / Revenue TTM 336.2m)
Gross Margin = 49.25% ((Revenue TTM 336.2m - Cost of Revenue TTM 170.6m) / Revenue TTM)
Gross Margin QoQ = 60.85% (prev 50.31%)
Tobins Q-Ratio = 0.84 (Enterprise Value 3.07b / Total Assets 3.67b)
Interest Expense / Debt = 5.17% (Interest Expense 139.4m / Debt 2.70b)
Taxrate = 0.84% (95.0k / 11.3m)
NOPAT = 129.1m (EBIT 130.2m * (1 - 0.84%))
Current Ratio = 4.71 (Total Current Assets 249.1m / Total Current Liabilities 52.9m)
Debt / Equity = 3.06 (Debt 2.70b / totalStockholderEquity, last quarter 883.1m)
Debt / EBITDA = 16.57 (Net Debt 2.64b / EBITDA 159.1m)
Debt / FCF = 37.49 (Net Debt 2.64b / FCF TTM 70.3m)
Total Stockholder Equity = 900.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.55% (Net Income 19.1m / Total Assets 3.67b)
RoE = 2.12% (Net Income TTM 19.1m / Total Stockholder Equity 900.6m)
RoCE = 3.68% (EBIT 130.2m / Capital Employed (Equity 900.6m + L.T.Debt 2.63b))
RoIC = 3.54% (NOPAT 129.1m / Invested Capital 3.65b)
WACC = 5.55% (E(431.4m)/V(3.13b) * Re(8.24%) + D(2.70b)/V(3.13b) * Rd(5.17%) * (1-Tc(0.01)))
Discount Rate = 8.24% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -56.10 | Cagr: -1.79%
[DCF] Terminal Value 73.14% ; FCFF base≈75.2m ; Y1≈66.1m ; Y5≈53.6m
[DCF] Fair Price = N/A (negative equity: EV 859.9m - Net Debt 2.64b = -1.78b; debt exceeds intrinsic value)
EPS Correlation: -96.88 | EPS CAGR: -25.25% | SUE: -2.59 | # QB: -3
Revenue Correlation: -87.52 | Revenue CAGR: -7.05% | SUE: 0.60 | # QB: 0
EPS current Quarter (2027-03-31): EPS=0.14 | Chg30d=-6.03% | Revisions=-38% | Analysts=8
EPS current Year (2026-12-31): EPS=0.52 | Chg30d=-9.53% | Revisions=-40% | GrowthEPS=-19.4% | GrowthRev=+70.3%
EPS next Year (2027-12-31): EPS=0.61 | Chg30d=-6.19% | Revisions=-38% | GrowthEPS=+18.8% | GrowthRev=-17.0%
[Analyst] Revisions Ratio: -53% (up=2, down=10)